University of Texas
601 Colorado Street
Austin
Texas
78701
United States
Tel: 512-499-4200
Fax: 512-499-4215
Website: http://www.utexas.edu/
Email: frmn@uts.cc.utexas.edu
389 articles about University of Texas
-
Researchers have developed a graphene-based e-tattoo that measures blood pressure continuously and has several advantages over the traditional blood pressure cuff.
-
INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
6/16/2022
Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between MD Anderson and National Resilience, Inc., today announced a strategic collaboration to jointly develop a reliable, compliant and scalable process for human leukocyte antigen (HLA)-G targeted chimeric antigen receptor (CAR) T cell therapy for solid tumors.
-
Researchers at the University of Texas at Austin shared results showing that their redesign of Cas9 makes it 4,000 times less likely to target the wrong stretch of DNA while still maintaining its efficiency.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry's COVID-19 stories that are trending for April 6, 2021.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Solutions from AMETEK Gatan Help Advance Coronavirus Vaccine Development
2/24/2020
Researchers at the University of Texas at Austin and the National Institutes of Health created the first 3D atomic scale map of the 2019 novel coronavirus.
-
A recent study questions if the FDA and other regulatory agencies worldwide rush certain approvals, particularly at the end of the year in a kind of “desk-clearing” activity.
-
It was another busy week for clinical trials. Here’s a look.
-
Acerus Signs License Agreement to Nasal Technology with University of Texas at Austin
5/30/2019
Acerus Pharmaceuticals Corporation announced that it has signed a patent license agreement with the University of Texas at Austin for technology related to the nasal administration of testosterone.
-
Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction
4/23/2019
2nd Gen Device Effectively Doubles the Peak Acoustic Pressure and Enables Deeper Penetration
-
A recent report by CBRE Research analyzing U.S. life science clusters, found that Houston, Texas is the third-fastest growing life science market from 2014 to 2017. One doesn’t typically think of Texas, let alone Houston, as being a center for the life sciences. Oil, energy and tech, yes, but not...
-
Soliton Initiated Clinical Trials for Treatment of Cellulite in Humans
4/1/2019
Soliton, Inc. summarized its efforts to conduct a proof of concept clinical trial for the treatment of cellulite based on Institutional Review Board approval of the study.
-
Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated
1/14/2019
Study underscores importance of sharing risks with patients considering lung cancer screening
-
MD Anderson immunologist Jim Allison awarded Nobel Prize
10/1/2018
T cell discoveries led to game-changing treatment revolutionizing cancer care
-
MD Anderson announces 2018 Andrew Sabin Family Fellows
6/7/2018
Eight awardees to pursue innovative cancer research through $100,000 two-year fellowships
-
University of Texas Health Science Center at Houston (UTHealth) Selects NovoPath™ Anatomic Pathology Software Platform for its Lab Information System
4/30/2018
NovoPath, Inc. announces that the University of Texas Health Science Center at Houston (UTHealth) has selected the NovoPath™ Anatomic Pathology Software Platform as its LIS for the Department of Pathology and Laboratory Medicine.
-
Revolutionary Pen Could Detect Cancer In 10 Seconds, University of Texas Study
9/11/2017